160 related articles for article (PubMed ID: 35618525)
1. In vitro fertilization with preimplantation genetic testing for monogenetic diseases versus unassisted conception with prenatal diagnosis for Huntington disease: a cost-effectiveness analysis.
Christensen AA; Parker PB; Hersh AR; Caughey AB; Krieg SA
Fertil Steril; 2022 Jul; 118(1):56-64. PubMed ID: 35618525
[TBL] [Abstract][Full Text] [Related]
2. Obstetric and Perinatal Outcomes in Pregnancies Conceived After Preimplantation Genetic Testing for Monogenetic Diseases.
Feldman B; Orvieto R; Weisel M; Aizer A; Meyer R; Haas J; Kirshenbaum M
Obstet Gynecol; 2020 Oct; 136(4):782-791. PubMed ID: 32925631
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of IVF with PGT-M/A to prevent transmission of spinal muscular atrophy in offspring of carrier couples.
Khorshid A; Boyd ALH; Behr B; Zhao Q; Alvero R; Bavan B
J Assist Reprod Genet; 2023 Apr; 40(4):793-801. PubMed ID: 36757555
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of preimplantation genetic testing for aneuploidy for women with subfertility in China: an economic evaluation using evidence from the CESE-PGS trial.
He X; Wang X; Shen J; Wan B; Wang Y; Zhang Z; Cai L; Bao Y; Ding H; Li X
BMC Pregnancy Childbirth; 2023 Apr; 23(1):254. PubMed ID: 37060068
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness of in vitro fertilisation and preimplantation genetic testing to prevent transmission of BRCA1/2 mutations.
Lipton JH; Zargar M; Warner E; Greenblatt EE; Lee E; Chan KKW; Wong WWL
Hum Reprod; 2020 Feb; 35(2):434-445. PubMed ID: 32099994
[TBL] [Abstract][Full Text] [Related]
6. Preimplantation genetic testing for BRCA gene mutation carriers: a cost effectiveness analysis.
Michaan N; Leshno M; Cohen Y; Safra T; Peleg-Hasson S; Laskov I; Grisaru D
Reprod Biol Endocrinol; 2021 Oct; 19(1):153. PubMed ID: 34620184
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of preimplantation genetic screening for women older than 37 undergoing in vitro fertilization.
Collins SC; Xu X; Mak W
J Assist Reprod Genet; 2017 Nov; 34(11):1515-1522. PubMed ID: 28748493
[TBL] [Abstract][Full Text] [Related]
8. Preimplantation genetics and other reproductive options in Huntington disease.
Blancato JK; Wolfe EM; Sacks PC
Handb Clin Neurol; 2017; 144():107-111. PubMed ID: 28947109
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of preimplantation genetic screening and in vitro fertilization versus expectant management in patients with unexplained recurrent pregnancy loss.
Murugappan G; Ohno MS; Lathi RB
Fertil Steril; 2015 May; 103(5):1215-20. PubMed ID: 25772770
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in preimplantation genetic diagnosis and screening.
Lu L; Lv B; Huang K; Xue Z; Zhu X; Fan G
J Assist Reprod Genet; 2016 Sep; 33(9):1129-34. PubMed ID: 27272212
[TBL] [Abstract][Full Text] [Related]
11. Preimplantation genetic testing for aneuploidy is cost-effective, shortens treatment time, and reduces the risk of failed embryo transfer and clinical miscarriage.
Neal SA; Morin SJ; Franasiak JM; Goodman LR; Juneau CR; Forman EJ; Werner MD; Scott RT
Fertil Steril; 2018 Oct; 110(5):896-904. PubMed ID: 30316435
[TBL] [Abstract][Full Text] [Related]
12. Preimplantation genetic diagnosis versus prenatal diagnosis-decision-making among pregnant FMR1 premutation carriers.
Haham LM; Avrahami I; Domniz N; Ries-Levavi L; Berkenstadt M; Orvieto R; Cohen Y; Elizur SE
J Assist Reprod Genet; 2018 Nov; 35(11):2071-2075. PubMed ID: 30136016
[TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of preimplantation genetic testing for aneuploidy in the United States: an analysis of cost and birth outcomes from 158,665 in vitro fertilization cycles.
Lee M; Lofgren KT; Thomas A; Lanes A; Goldman R; Ginsburg ES; Hornstein MD
Am J Obstet Gynecol; 2021 Jul; 225(1):55.e1-55.e17. PubMed ID: 33539823
[TBL] [Abstract][Full Text] [Related]
14. Non-disclosing preimplantation genetic diagnosis for Huntington disease.
Stern HJ; Harton GL; Sisson ME; Jones SL; Fallon LA; Thorsell LP; Getlinger ME; Black SH; Schulman JD
Prenat Diagn; 2002 Jun; 22(6):503-7. PubMed ID: 12116316
[TBL] [Abstract][Full Text] [Related]
15. Preimplantation genetic testing for sickle cell disease: a cost-effectiveness analysis.
Combs JC; Dougherty M; Yamasaki MU; DeCherney AH; Devine KM; Hill MJ; Rothwell E; O'Brien JE; Nelson RE
F S Rep; 2023 Sep; 4(3):300-307. PubMed ID: 37719105
[TBL] [Abstract][Full Text] [Related]
16. Clinical validity and utility of preconception expanded carrier screening for the management of reproductive genetic risk in IVF and general population.
Capalbo A; Fabiani M; Caroselli S; Poli M; Girardi L; Patassini C; Favero F; Cimadomo D; Vaiarelli A; Simon C; Rienzi LF; Ubaldi FM
Hum Reprod; 2021 Jun; 36(7):2050-2061. PubMed ID: 34021342
[TBL] [Abstract][Full Text] [Related]
17. Minimizing mosaicism: assessing the impact of fertilization method on rate of mosaicism after next-generation sequencing (NGS) preimplantation genetic testing for aneuploidy (PGT-A).
Palmerola KL; Vitez SF; Amrane S; Fischer CP; Forman EJ
J Assist Reprod Genet; 2019 Jan; 36(1):153-157. PubMed ID: 30362056
[TBL] [Abstract][Full Text] [Related]
18. Is IVF-served two different ways-more cost-effective than IUI with controlled ovarian hyperstimulation?
Tjon-Kon-Fat RI; Bensdorp AJ; Bossuyt PM; Koks C; Oosterhuis GJ; Hoek A; Hompes P; Broekmans FJ; Verhoeve HR; de Bruin JP; van Golde R; Repping S; Cohlen BJ; Lambers MD; van Bommel PF; Slappendel E; Perquin D; Smeenk J; Pelinck MJ; Gianotten J; Hoozemans DA; Maas JW; Groen H; Eijkemans MJ; van der Veen F; Mol BW; van Wely M
Hum Reprod; 2015 Oct; 30(10):2331-9. PubMed ID: 26269539
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of prenatal screening methods for congenital heart defects in pregnancies conceived by in-vitro fertilization.
Chung EH; Lim SL; Havrilesky LJ; Steiner AZ; Dotters-Katz SK
Ultrasound Obstet Gynecol; 2021 Jun; 57(6):979-986. PubMed ID: 32304621
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of in vitro fertilization with preimplantation genetic screening: a reanalysis of United States assisted reproductive technology data 2011-2012.
Kushnir VA; Darmon SK; Albertini DF; Barad DH; Gleicher N
Fertil Steril; 2016 Jul; 106(1):75-79. PubMed ID: 26952783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
